Advanced Life Science Institute, Inc. is a Japanese company located in Tokyo that manufactures and wholesales testing drugs of hepatitis viruses and lung cancers. It was founded in 1997.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Autobio Diagnostics is a company mainly engaged in development, manufacture and sales of diagnostics products.

Sanyo Chemical Industries, Ltd. engages in the manufacture and sale of chemicals. It operates through the following segments: Toiletries and Health Care; Petroleum and Automotives; Plastics and Textiles; Information and Electronics; and Environmental Protection, Construction, and Others. The Toiletries and Health Care segment manufactures and supplies surfactants for detergents, cleaning agents, and toiletries; pharmaceutical additives; and superabsorbent polymers. The Petroleum and Automotives segment develops and distributes thermoplastic polyurethane beads (TUB) for the interior parts of automobiles, raw materials for polyurethane foams, and lubricating oil additives. The Plastics and Textiles segment offers permanent antistatic agents, and carbon fiber and fiberglass agents. The Information and Electronics segment includes polymerization toners, toner binders, and electrolytes for aluminum electrolytic capacitors. The Environmental Protection, Construction, and Others segment manufactures and distributes polymer flocculants for wastewater treatment, and polyurethane insulation raw materials. The company was founded on November 1, 1949 and is headquartered in Kyoto, Japan.

Beijing Kewei Clinical Diagnostic Reagent Co., Ltd., established on 1990-03-06, The scope of business includes the production of in vitro diagnostic reagents[Hepatitis B virus surface antigen diagnostic kit(law),Hepatitis C virus antibody diagnostic kit(law),Human Immunodeficiency Virus Antigen Antibody Diagnostic Kit(law),Treponema pallidum antibody diagnostic kit(law)];ProductionIII,IIkind:III,II-6840In vitro diagnostic reagents;Sales of medical devicesIII:6840Clinical laboratory analysis instruments and diagnostic reagents(Contains diagnostic reagents);Sales of medical devicesIIkind:6822Medical Optics,Instruments and endoscopic equipment,6840Clinical laboratory analysis instruments and diagnostic reagents(Contains diagnostic reagents),6854operating room,emergency room,Consulting room equipment and appliances;Import and export,Technology Import and Export,Agent import and export;technology development,consult;rental medical equipment;Repair medical equipment.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of in vitro diagnostic reagents[Hepatitis B virus surface antigen diagnostic kit(law),Hepatitis C virus antibody diagnostic kit(law),Human Immunodeficiency Virus Antigen Antibody Diagnostic Kit(law),Treponema pallidum antibody diagnostic kit(law)]and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Dongguan Pengzhi Biotechnology Co., Ltd., established on 2016-08-22, Business scope includes biological products,R&D of medical devices,Production,Sales and technology transfer,Technical Services;Sales:Chemical Products(Free of Hazardous Chemicals);Import and export,Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

TonenGeneral Sekiyu K.K. is a Japan-based company engaged in the import, transportation, refining, manufacture and sale of crude oil, petroleum products and petrochemical products, among others. The Company has two business segments. The Petroleum segment is engaged in the production, processing and sale of petroleum products, the transportation of crude oil and petroleum products, the purchase and sale of liquefied natural gas (LNG), the procurement and sale of biomass fuels, as well as the holding of shares. The Petrochemical Product segment is involved in the production, processing and sale of petrochemical products.

Chemclin Diagnostics Co., Ltd. engages in the research, development, production, and sales of vitro diagnostic reagents and instruments for clinical immuno chemiluminescence diagnosis in China. Its products are LiCA series of diagnostic reagents based on photoexcitation chemiluminescence, and CC series diagnostic reagents and instruments based on enzymatic chemiluminescence. The company's products are used in the detection of infectious diseases such as hepatitis B, C, AIDS, syphilis, hepatitis A, and hepatitis E markers, tumor markers, thyroid hormones, reproductive endocrine hormones, and myocardial markers and inflammation. Chemclin Diagnostics was founded on May 10, 2007and is headquartered in Beijing, China.

Dirui Industrial Co., Ltd. engages in the research and development, production, and sale of medical testing instrument, and supporting test paper reagents. Its products include urinalysis, biochemical analysis, blood cell analysis, chemiluminescence immunoassay, gynecological secretion analysis, coagulation analysis, and standard laboratory testing systems. The company was founded by Yong Song and Jie Song on April 15, 1992 and is headquartered in Changchun, China.

Chongqing Kangju Quanhong Biotechnology Co., Ltd., established on 2017-02-28, Business scope includes licensed projects:IIIResearch and development of similar medical devices,Production,Sales;drug development,Production,Sales;Import and export business of goods and technology(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:I,IIResearch and development of similar medical devices,Production,Sales;Biomedical Technology Consulting;Engaged in technology development in the field of medicine,technical consulting,Technical Services;laboratory equipment,Research and development of office equipment,Production,Sales;Engage in technology development in the computer field,technical consulting,Technical Services,technology transfer;Warehousing Services(Does not contain dangerous goods storage);Business Consulting(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenzhen New Industries Biomedical Engineering Co., Ltd. principally engages in the research, development, production, and sale of automatic chemiluminescence immunoassay instruments and supporting reagents. The company was founded on December 15, 1995 and is headquartered in Shenzhen, China.

CUSABIO is a National High-Tech Enterprise with research, production and sales in one. After 11 years of effort, CUSABIO has become a good partner to researchers through worldwide. We are dedicated to providing 60,000+ validated antibodies, 6000+ recombinant proteins, 580+ cytokines and thousands of ELISA kits to global customers in the research fields of cancer, cell biology, immunology, neuroscience, epigenetics, etc. All kinds of our products can meet customers' different demands in various scientific research fields.

Nanjing Wenzhi Biotechnology Co., Ltd., established on 2013-04-26, Business scope includes research and development of biotechnology and products,technology transfer,Technical extension services;Sales of biomedical products and provide corresponding technical consultation and technical services;Clinical Medical Research Services;Chemical raw materials and chemical reagents(Free of Hazardous Chemicals),biological raw material(except food and medicine),biological reagent,Raw materials for in vitro diagnostic reagents,Technical development of biological products,Technical Consulting and Sales;Medical device research and development,Sales and technical consultation,Technical Services;Office Supplies,Daily necessities,Electronics and Accessories,Sales of computer consumables;Development and maintenance of computer software and hardware;Housekeeping;food sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Bell Medical Equipment Co., Ltd., established on 2013-06-17, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Machinery sales;Instrument sales;Class I Medical Device Leasing;Class II Medical Device Leasing;Import and export;Production of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Hangzhou Weixin Biotechnology Co., Ltd., established on 2015-12-03, Business scope includes technology development,Technical Services,technical consulting,Achievement transfer:Biotechnology,Computer hardware and software,computer network Technology,electronic product

YHLO specializes in the development and production of in-vitro diagnostic instruments and reagents. The company offers a broad range of instruments (based on Chemiluminescence, ELISA, Immunoblot, and Immunofluorescence methodologies) with patented technologies and outstanding features, as well as a comprehensive total solution with portfolios in fertility and reproductive health, diabetes, infectious diseases, autoimmune disorders and other novel assays on rare diseases analysis.

Shenzhen Zhaolan Biotechnology Co., Ltd., established on 2016-06-22, Business scope includes general business items:biologically active protein,antigenic protein,antibody protein,antigen enzyme-labeled protein,antibody enzyme-labeled protein,Research and development of reagent intermediates and non-medical device consumables,Sales and after-sales service;medical instruments,application,Research and development of electronic equipment and related consumables,Sales and after-sales service;Domestic Trade(Does not contain franchise,monopoly,Specially Controlled Commodities);Operating import and export business;business services;Technical development of biological products;Technology development of biotechnology products;Science and Technology Information Consulting.(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:biologically active protein,antigenic protein,antibody protein,antigen enzyme-labeled protein,antibody enzyme-labeled protein,Reagent intermediates and non-medical device consumables,medical instruments,application,Production of electronic equipment and related consumables;Class III medical devices(In vitro diagnostic reagents)production.

Jiangsu Fulong Biotechnology Co., Ltd., established on 2008-06-10, The business scope includes products in the field of life sciences,Central Nervous Kit(Nerve Detection Reagents,Rapid Golgi Staining Reagent,cell death reagent)Research,to develop;Food Safety Testing Reagents(Colloidal gold quick test card,ELISAReagent test kit)Research,to develop,Production,Sales;Research on In Vitro Diagnostic Reagents,to develop,Technical Services;Research on biotherapeutic technology,to develop,Serve;Production of food safety testing instruments,Sales;Class I medical device sales;Class II medical device sales;Class III medical device sales(according to<Medical Device Business License>Approved range sales);Class I medical device,Class II medical device,Technology research and development of three types of medical devices,Technical Services,technical consulting;Production of Class I Medical Devices,Production of Class II Medical Devices(according to<Medical device production license>Approved scope of production);Production of Class III Medical Devices(according to<Medical device production license>Approved scope of production);biomaterials(Dehazardous chemicals)promotion of;Self-operated and agent import and export business of various commodities and technologies,Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)